Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : INVI Invitro International -- Ignore unavailable to you. Want to Upgrade?

To: Richard Mazzarella who wrote (362)	4/2/1998 6:11:00 PM
From: Coral4pH_dot_com	Read Replies (1) \| Respond to of 486

Richard, The merger with Miragen doesn't look good due to lack of financial backing ... and I indicated that things may be worse without a merger. The reason for this logic is due to the fact that InVitro lost money even in their BEST quarter and with Rich Ulmer temporarirly waiving his salary. With SO, SO many cutbacks and expense reductions and with InVitro still not making a profit, it is going to take ALOT to get ahead and move forward. Now, you are correct, if the NON-ANIMAL testing movement sees success and industries start to adapt these new testing methods, we could see some big opportunities. But, we have been saying this for several years now. I hear it could be several more years before the ban in Europe is actually implemented ... so things do not look very promising at all. Investors of this stock need to be willing to lose every last penny. If this stock surprises us and there are HUGE turn-arounds with interest in what InVitro does, then the flip-side can be very rewarding. I am trying to see this from all sides and avoid the appearance of hyping or slamming, but be logical ... but not as bad as spock.